Inventor · disambiguated record
Robert T. Lum
Also filed as: LUM ROBERT · LUM ROBERT T
20 granted patents·3 pending applications·646 citations·filing 1995–2023
95Inventor score
Top patents by PatentIndex Score
23 records- 0194US5866702APurine inhibitors of cyclin dependent kinase 2CV THERAPEUTICS INC·Filed 1996·Granted Feb 2, 1999·142 cites·6 claims
- 0293US6794390B2Purine inhibitors of cyclin dependent kinase 2 & ikappabalphaCV THERAPEUTICS INC·Filed 2001·Granted Sep 21, 2004·43 cites·11 claims
- 0391US6075150Aα-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1998·Granted Jun 13, 2000·96 cites·2 claims
- 0491US5789416AN6 mono heterocyclic substituted adenosine derivativesCV THERAPEUTICS INC·Filed 1996·Granted Aug 4, 1998·107 cites·14 claims
- 0588US6506739B1Bis-(N,N'-bis-(2-haloethyl)amino)phosphoramidates as antitumor agentsTELIK INC·Filed 2001·Granted Jan 14, 2003·26 cites·20 claims
- 0687US7029695B2Therapeutic compositions containing glutathione analogsTELIK INC·Filed 2001·Granted Apr 18, 2006·31 cites·18 claims
- 0783US6337338B1Heteroaryl-aryl ureas as IGF-1 receptor antagonistsTELIK INC·Filed 1999·Granted Jan 8, 2002·72 cites·22 claims
- 0882US6781000B1Alpha-ketoamide inhibitors of 20S proteasomeCV THERAPEUTICS INC·Filed 1999·Granted Aug 24, 2004·50 cites·14 claims
- 0970US5834487AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS·Filed 1996·Granted Nov 10, 1998·27 cites·11 claims
- 1066US6479548B2Substituted stilbenes as glucose uptake enhancersTELIK INC·Filed 2001·Granted Nov 12, 2002·5 cites·22 claims
- 1165US11834412B2Derivatives of aryl hydrocarbon receptor agonistsAZORA THERAPEUTICS INC·Filed 2023·Granted Dec 5, 2023·0 cites·21 claims
- 1265US7071231B2Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2002·Granted Jul 4, 2006·2 cites·20 claims
- 1362US6458998B1Naphthalene ureas as glucose uptake enhancersTELIK INC·Filed 2000·Granted Oct 1, 2002·1 cites·37 claims
- 1459US6790958B2Purine inhibitors of cyclin dependent kinase 2 & IKBAFiled 2001·Granted Sep 14, 2004·16 cites·3 claims
- 1554US5656660ACompositions and methods for treating mast-cell mediated conditionsARRIS PHARM CORP·Filed 1995·Granted Aug 12, 1997·14 cites·42 claims
- 1652US7109330B2Purine inhibitors of cyclin dependent kinase 2 and IκB-αCV THERAPEUTICS INC·Filed 2004·Granted Sep 19, 2006·6 cites·3 claims
- 1751US6117887AInhibition of 26S and 20S proteasome by indanonesCV THERAPEUTICS INC·Filed 1998·Granted Sep 12, 2000·8 cites·9 claims
- 1850US8361971B2Tablet formulation of ezatiostatTELIK INC·Filed 2011·Granted Jan 29, 2013·0 cites·22 claims
- 1942US6528037B2Method for determining whether a compound is an insulin receptor kinase activatorTELIK INC·Filed 2002·Granted Mar 4, 2003·0 cites·5 claims
- 2040US2012283325A1Excipient compatibility with ezatiostatLUM ROBERT T·Filed 2012·Application pending·0 cites
- 2140US2011300215A1Tablet formulation of ezatiostatLUM ROBERT T·Filed 2011·Application pending·0 cites
- 2240US2002061927A1Insulin receptor activators for the treatment of metabolic disorders induced by treatment with HIV protease inhibitorsFiled 2001·Application pending·0 cites
- 2336US6653321B1Naphthylsulfonic acids and related compounds as glucose uptake agonistsTELIK INC·Filed 2000·Granted Nov 25, 2003·0 cites·30 claims
Join the waitlist — get patent alerts
Get an alert when Robert T. Lum files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →